WW International, Inc. operates the Weight Watchers weight-management platform through digital, workshop and clinical subscription offerings. Company news commonly covers subscriber trends, subscription revenue, adjusted operating measures and the balance between its Behavioral business and its Clinical business.
Recurring updates also include expansion of the Med+ clinical offering, access to FDA-approved GLP-1 treatment options through affiliated medical groups, debt-reduction actions involving its term loan, and governance changes such as board appointments, committee assignments and interim executive-leadership structure.
Weight Watchers (Nasdaq: WW) reported third-quarter 2026 net income of $15.1 million, reversing a loss in the year-earlier quarter. Revenue fell 11% to $152.9 million, while Clinical subscription revenue rose 48% to $38.0 million. The prior-year net loss was $57.5 million. Adjusted EBITDA, a non-GAAP earnings measure, increased 21% to $51.7 million.
Total quarter-end subscribers were 2.3 million. Clinical subscribers grew 40% year over year to 174 thousand, and Core+ subscribers rose 16% to 546 thousand. Gross margin declined to 71.1% from 72.1%. Cash reached $126.4 million, up from $101.5 million at the second-quarter end but below $160.3 million at year-end 2025.
The company narrowed its fiscal 2026 outlook to revenue of $625 million–$630 million and adjusted EBITDA of $110 million–$115 million, from $620 million–$635 million and $105 million–$115 million, respectively.
Weight Watchers (WW) will release its third-quarter 2026 results before market open on November 5, 2026. The quarter ended September 30, 2026. A conference call to discuss the results will begin at 8:30 a.m. ET that day. The webcast will be available at corporate.ww.com under Events and Presentations, with a replay available for at least 90 days.
Weight Watchers (WW) has launched a collaboration with Google Health Enterprise for select employer-sponsored weight health programs. Available now through select Weight Watchers for Business client programs, it lets eligible members connect Google Fitbit Air to their Weight Watchers accounts. Access to Fitbit Air and Google Health Premium follows completion of required activity and duration milestones.
WW International (WW) appointed Stephen Bye as President and Chief Executive Officer and to its Board of Directors, with his appointment effective this fall.
Bye most recently served as President and CEO of Ookla, where he transformed and scaled the connectivity intelligence business, growing subscription revenue and improving operational efficiency and profitability while integrating multiple acquisitions. The Weight Watchers board highlights his experience in consumer subscription and product businesses, leading companies through industry disruption, and driving profitable growth and shareholder value.
With more than 30 years of leadership across major communications and technology companies, Bye is expected by the company to help advance Weight Watchers’ strategy of building an integrated weight health platform for the GLP-1 era that combines behavioral support, clinical care and access to GLP-1 medications with technology and data-driven personalization.
Weight Watchers (WW) will participate in the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15, 2026. The company will host a fireside chat starting at 2:35 p.m. ET, which will focus on its science-backed weight management approach and healthcare positioning.
The fireside chat will be available via live audio webcast on the corporate website at corporate.ww.com under the Events and Presentations section. A replay of the webcast will be accessible on the site for at least 90 days. Weight Watchers highlights its integrated support system for the GLP-1 era, combining scientific expertise, medication, technology, and human support across consumer and business channels.
Weight Watchers (Nasdaq: WW) reported Q2 2026 revenue of $162.3 million, including $39.9 million in Clinical Subscription Revenue, up 30.4% year-over-year. Total end-of-period subscribers were 2.5 million, with Clinical subscribers of 197 thousand, up 55.7% year-over-year, and Core+ Behavioral subscribers of 541 thousand, up 13.9%, marking a third consecutive quarter of sequential growth.
Q2 Monthly Subscription ARPU increased 10.2% year-over-year. Gross margin was 70.3% and Adjusted Gross Margin 73.6%. Marketing expense was $47.9 million, or 29.5% of revenue. Net income was $14.1 million and Adjusted EBITDA $39.8 million. Operating cash flow reached $24.3 million, with cash of $101.5 million at June 30, 2026. The company prepaid $36.8 million on its term loan, cutting principal by $41.4 million and annualized interest by about $4 million, and reaffirmed full-year 2026 revenue guidance of $620–$635 million and Adjusted EBITDA of $105–$115 million.
Weight Watchers (NASDAQ: WW) plans to release its second quarter 2026 results, for the period ended June 30, 2026, after market close on Wednesday, August 5, 2026. The company will host an earnings conference call at 5:00 p.m. ET, with a live webcast and a replay available for at least 90 days on its corporate website.
Weight Watchers (NASDAQ:WW) announced a collaboration with Sam’s Club to expand affordable, holistic wellness options for Sam’s Club members.
Sam’s Club Plus members may receive a complimentary three-month Weight Watchers Core membership, then continue for $10 per month, while all members get up to 50% off select WW programs, including Core+ and Med+ with GLP-1 support and integrated pharmacy services.
Weight Watchers (NASDAQ: WW) and FlavCity announced a summer collaboration centered on strength, nutrition, and community. The partnership introduces a limited-edition Whipped Lemonade protein smoothie powder with 25g protein, 10g collagen, no artificial flavors, and a 4 Points value, sold via FlavCity’s TikTok Shop and website.
Alongside the product, Weight Watchers launched Summer Strength Club, a 10-week experience with live Friday strength classes led by Global Strength Coach Holly Rilinger, nutrition content featuring the new flavor, recipes, coaching, and an in-app community challenge for members and non-members.
Weight Watchers (NASDAQ:WW) announced that Weight Watchers Med+ will support Medicare beneficiaries accessing GLP-1 medications via the Medicare GLP-1 Bridge Program.
Eligible members with Medicare Part D can obtain select GLP-1 weight-loss drugs for $50 per month from July 1, 2026 through December 31, 2027, alongside Med+ clinical and behavioral support.
According to Weight Watchers, Med+ members on GLP-1s who engaged with the GLP-1 Success Program lost 29.1% more body weight at 12 months, and 73% reported that Med+ helps minimize medication side effects.